Skip to content

GeneLit

Taming the Medical Literature ~ For Genetic Conditions ~ Hand-Curated • Direct to You

  • Home
  • Subscribe to GeneLit
  • Conditions & Syndromes
    • Genetics of Breast & Ovarian Cancer
  • Topics
  • Contact GeneLit
  • Get LitAlerts
  • Terms and Conditions

Home

    • Dr. DiSilvestro on the Long-Term OS Benefit of Olaparib Maintenance in Ovarian Cancer.
    • DiSilvestro PA.
    • OncLive. 2022 Oct 24.
    • Video
    • Free video

    Related:

    •• Identifier: NCT01844986: Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy. (SOLO-1). (ClinicalTrials.gov . Accessed 2022 Oct 25)

  • Posted on October 25, 2022October 25, 2022Author Steve KopczakCategories All HBOC

    Post navigation

    Previous Previous post: Previous Post
    Next Next post: Next Post
    Proudly powered by WordPress